| Vorasidenib studied in …STUDIED_INderived15 of 15show fewer |
|---|
| → studied in | NCT06809322Phase 3 · recruiting Vorasidenib Maintenance for IDH Mutant Astrocytoma · 15 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215910Phase 3 · recruiting Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer · 15 trials list this drug (10 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05592743approved for marketing Vorasidenib Expanded Access Program · 15 trials list this drug (10 active) | — | — | Neoplasm,Neuroepithelial Neoplasm,Primitive Neuroectodermal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06969352NA · active not recruiting A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study) · 15 trials list this drug (10 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478212Phase 1/Phase 2 · active not recruiting Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma · 15 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629089Phase 1 · not yet recruiting VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations · 15 trials list this drug (10 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780930Phase 3 · active not recruiting Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation · 15 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07547163recruiting Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared · 15 trials list this drug (10 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05484622Phase 1 · active not recruiting Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma · 15 trials list this drug (10 active) | — | — | Astrocytoma,Oligodendroglioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02481154Phase 1 · completed Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation · 15 trials list this drug (10 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03343197Phase 1 · completed Study of AG-120 and AG-881 in Subjects With Low Grade Glioma · 15 trials list this drug (10 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07235748Phase 1 · completed Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants · 15 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07240662recruiting Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma · 15 trials list this drug (10 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164901Phase 3 · active not recruiting Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) · 15 trials list this drug (10 active) | — | — | Glioma,WHO Grade 2 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02492737Phase 1 · completed Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation · 15 trials list this drug (10 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |